Related Experiment Video
Updated: May 3, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Nin one binding protein expression as a prognostic marker in prostate carcinoma
1Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Nin one binding protein (Nob1) is highly expressed in prostate cancer, indicating a poor prognosis. Higher Nob1 levels correlate with aggressive disease features and shorter recurrence-free survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate carcinoma is a significant health concern.
- Identifying prognostic markers is crucial for patient management.
Purpose of the Study:
- To evaluate the prognostic significance of nin one binding protein (Nob1) expression in prostate cancer.
Main Methods:
- Western blot and immunohistochemistry were used to assess Nob1 protein levels in prostate cancer tissues and controls.
- Expression levels were correlated with clinical-pathological parameters and patient outcomes.
Main Results:
- Nob1 expression was significantly higher in prostate carcinomas compared to non-neoplastic tissues (58% vs 7%).
- Increased Nob1 levels were associated with high Gleason scores and metastasis.
- Nob1 expression independently predicted shorter biochemical recurrence-free survival (BCRFS).
Conclusions:
- Nin one binding protein (Nob1) serves as a valuable indicator of poor prognosis in prostate carcinoma.
- Nob1 may be a potential therapeutic target for improving patient outcomes.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
